Safety and immunogenicity of measles-mumps-rubella vaccine in children with congenital immunodeficiency (DiGeorge syndrome)

Vaccine

Volumn 23, Issue 14, 2005, Pages 1668-1671

  Azzari, Chiara ^a   Gambineri, Eleonora ^a   Resti, Massimo ^a   Moriondo, Maria ^a   Betti, Letizia ^a   Saldias, Lucien Rojas ^a   Gelli, Anna M G ^a   Vierucci, Alberto ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Congenital immunodeficiency; DiGeorge anomaly; MMR vaccine

Indexed keywords

ANTIBODY; CD4 ANTIGEN; MEASLES MUMPS RUBELLA VACCINE;

ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIGEORGE SYNDROME; DISEASE SEVERITY; DRUG SAFETY; EDEMA; ERYTHEMA; FEVER; HUMAN; IMMUNE DEFICIENCY; IMMUNIZATION; IMMUNOGENICITY; MEASLES; MUMPS; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; RUBELLA; SEROCONVERSION; SIDE EFFECT; SKIN MANIFESTATION; T LYMPHOCYTE; VACCINATION;

EID: 13444310815     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.10.005     Document Type: Article

References (19)

1. Recommendations of the advisory committee on immunization practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence. MMWR Recomm Rep 1993;42(RR-4):1-18.
2. L.J. Kaplan, R.S. Daum, M. Smaron, and C.A. McCarthy Severe measles in immunocompromised patients JAMA 267 9 1992 1237 1241
3. K. Krasinski, and W. Borkowsky Measles and measles immunity in children infected with human immunodeficiency virus JAMA 261 17 1989 2512 2516
4. W.J. Moss, C.J. Clements, and N.A. Halsey Immunization of children at risk of infection with human immunodeficiency virus Bull World Health Organ 81 1 2003 61 70
5. E.E. Perez, A. Bokszczanin, D. McDonald-McGinn, E.H. Zackai, and K.E. Sullivan Safety of live viral vaccines in patients with chromosome 22q11.2 deletion Syndrome (DiGeorge syndrome/velocardiofacial syndrome) Pediatrics 112 4 2003 e325
6. A. de la Chapelle, R. Herva, M. Koivisto, and P. Aula A deletion in chromosome 22 can cause DiGeorge syndrome Hum Genet 57 3 1981 253 256
7. H.W. Lischner, and A.M. DiGeorge Role of the thymus in humoral immunity Lancet 2 7629 1969 1044 1049
8. A.F. Jawad, D.M. McDonald-McGinn, E. Zackai, and K.E. Sullivan Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) J Pediatr 139 5 2001 715 723
9. C.J. White, D. Stinson, B. Staehle, I. Cho, H. Matthews, and A. Ngai Measles, mumps, rubella, and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. Measles, mumps, rubella, varicella vaccine study group Clin Infect Dis 24 5 1997 925 931
10. L.A. Mitchell, A.J. Tingle, D. Decarie, and C. Lajeunesse Serologic responses to measles, mumps, and rubella (MMR) vaccine in healthy infants: failure to respond to measles and mumps components may influence decisions on timing of the second dose of MMR Can J Public Health 89 5 1998 325 328
11. M. Muscat, S. Glismann, and H. Bang Measles in Europe Euro Surveill 8 6 2003 123 138
12. M. McLaughlin, P. Thomas, I. Onorato, A. Rubinstein, J. Oleske, and S. Nicholas Live virus vaccines in human immunodeficiency virus-infected children: a retrospective survey Pediatrics 82 2 1988 229 233
13. P. Goon, B. Cohen, L. Jin, R. Watkins, and G. Tudor-Williams MMR vaccine in HIV-infected children - potential hazards? Vaccine 19 28-29 2001 3816 3819
14. J.B. Angel, P. Walpita, R.A. Lerch, M.S. Sidhu, M. Masurekar, and R.A. DeLellis Vaccine-associated measles pneumonitis in an adult with AIDS Ann Intern Med 129 2 1998 104 106
15. M. Virtanen, H. Peltola, M. Paunio, and O.P. Heinonen Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination Pediatrics 106 5 2000 e62
16. S.M. Arpadi, L.E. Markowitz, A.L. Baughman, K. Shah, H. Adam, and A. Wiznia Measles antibody in vaccinated human immunodeficiency virus type 1-infected children Pediatrics 97 5 1996 653 657
17. I. Al-Attar, J. Reisman, M. Muehlmann, and K. McIntosh Decline of measles antibody titres after immunization in human immunodeficiency virus-infected children Pediatr Infect Dis J 14 2 1995 149 151
18. A.L. Pukhalsky, G.V. Shmarina, M.S. Bliacher, I.M. Fedorova, A.P. Toptygina, and J.J. Fisenko Cytokine profile after rubella vaccine inoculation: evidence of the immunosuppressive effect of vaccination Mediators Inflamm 12 4 2003 203 207
19. B. Rager-Zisman, E. Bazarsky, A. Skibin, S. Chamney, I. Belmaker, and I. Shai The effect of measles-mumps-rubella (MMR) immunization on the immune responses of previously immunized primary school children Vaccine 21 19-20 2003 2580 2588